Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia

Blood

Volumn 92, Issue 11, 1998, Pages 4072-4079

  Knechtli, Christopher J C ^b   Goulden, Nicholas J ^b   Hancock, Jeremy P ^b   Grandage, Victoria L G ^b   Harris, Emma L ^b   Garland, Russell J ^b   Jones, Claire G ^b   Rowbottom, Anthony W ^b   Hunt, Linda P ^b   Green, Ann F ^b   Clarke, Emer ^b   Lankester, Alan W ^b   Cornish, Jacqueline M ^b   Pamphilon, Derwood H ^b   Steward, Colin G ^a   Oakhill, Anthony ^b  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; FEMALE; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN GENE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T LYMPHOCYTE RECEPTOR GENE; TREATMENT OUTCOME;

EID: 0032400846     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4072.423k33_4072_4079     Document Type: Article

References (54)

1. Ramsay NK, Kersey JH: Indications for marrow transplantation in acute lymphoblastic leukemia. Blood 75:815, 1990
2. Barrett AJ: Bone marrow transplantation for acute lymphoblastic leukaemia. Baillieres Clin Haematol 7:377, 1994
3. Dopfer R, Henze G, Bender-Gotze C, Ebell W, Ehninger G, Friedrich W, Gadner H, Klingebiel T, Peters C, Riehm H: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: Results of the German Cooperative Study. Blood 78:2780, 1991
4. Barren AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan, GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA: Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 331:1253, 1994
5. Chessells JM, Rogers DW, Leiper AD, Blacklock H, Plowman PN, Richards, Levinsky R, Festenstein H: Bone-marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemia. Lancet 1:1239, 1986
6. Chessells JM, Bailey C, Wheeler K, Richards SM: Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X. Lancet 340:565, 1992
7. Barrett AJ, Horowitz MM, Gale RP, Biggs JC, Camitta BM, Dicke KA, Gluckman E, Good RA, Herzig RH, Lee MB: Marrow transplantation for acute lymphoblastic leukemia: Factors affecting relapse and survival. Blood 74:862, 1989
8. Herzig RH, Bortin MM, Barren AJ, Blume KG, Gluckman E, Horowitz MM, Jacobsen SJ, Marmont A, Masaoka T, Prentice HG: Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission. Lancet 1:786, 1987
9. Butturini A, Rivera GK, Bortin MM, Gale RP: Which treatment for childhood acute lymphoblastic leukaemia in second remission? Lancet 1:429, 1987
10. Weisdorf DJ, Woods WG, Nesbit MEJ, Uckun F, Dusenbery K, Kim T, Haake R, Thomas W, Kersey JH, Ramsay NK: Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: Risk factors and clinical outcome. Br J Haematol 86:62, 1994
11. Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC: Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time - A report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplant 17:13, 1996
12. Chao NJ, Forman SJ, Schmidt GM, Snyder DS, Amylon MD, Konrad PN, Nademanee AP, O'Donnell MR, Parker PM, Stein AS: Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood 78:1923, 1991
13. Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf, EW, Appelbaum FR, Buckner CD, Matthews D, Storb R: Unrelated donor marrow transplantation in children. Blood 86:3247, 1995
14. Oakhill A, Pamphilon DH, Potter MN, Steward CG, Goodman S, Green A, Goulden P, Goulden NJ, Hale G, Waldmann H, Cornish JM: Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 94:574, 1996
15. Wheeler K, Richards S, Bailey C, Chessells J: Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia - The MRC UKALL X experience. Br J Haematol 101:93, 1998
16. Giralt SA, Champlin RE: Leukemia relapse after allogeneic bone marrow transplantation: A review. Blood 84:3603, 1994
17. Mehta J, Powles R, Horton C, Milan S, Treleaven J, Tait D, Catovsky D: Bone marrow transplantation for primary refractory acute leukaemia. Bone Marrow Transplant 14:415, 1994
18. Giona F, Testi AM, Annino L, Amadori S, Arcese W, Camera A, Di, Montezemolo LC, Ladogana S, Liso V, Meloni G: Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: The GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologia ed Ocologia Pediatrica. Br J Haematol 86:55, 1994
19. Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W, Jacobsen N, Phillips GL, Rimm AA, Ringden O: Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 80:1090, 1992
20. Bortin MM, Horowitz MM, Gale RP, Barrett AJ, Champlin RE, Dicke KA, Gluckman E, Kolb HJ, Marmont AM, Mrsic M: Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. JAMA 268:607, 1992
21. Chao NJ, Forman SJ: Allogeneic bone marrow transplantation for acute lymphoblastic leukemia, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell Scientific, 1994, p 618
22. Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, Appelbaum FR, Bryant E, Chauncey TR, Sale G, Sanders JE, Storb R, Sullivan KM, Anasetti C: Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 89:4226, 1997
23. Uckun FM, Kersey JH, Haake R, Weisdorf D, Nesbit ME, Ramsay NK: Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N Engl J Med 329:1296, 1993
24. Seriu T, Yokota S, Nakao M, Misawa S, Takaue Y, Koizumi S, Kawai S, Fujimoto T: Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation. Leukemia 9:615, 1995
25. Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, Slater RM, von dem Borne AE, van der School CE: Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia. Leukemia 9:1726, 1995
26. Vervoordeldonk SF, Merle PA, Behrendt H, Steenbergen EJ, van den Berg H, van Wering ER, von dem Borne AE, van der Schoot CE, van Leeuwen EF, Slaper-Cortenbach IC: PCR-positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B-cell acute leukaemia. Br J Haematol 96:395, 1997
27. Campana D, Pui CH: Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood 85:1416, 1995
28. Cole-Sinclair MF, Foroni L, Hoffbrand AV: Genetic changes: Relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia. Baillieres Clin Haematol 7:183, 1994
29. Knechtli CJC, Goulden NJ, Langlands K, Potter MN: The study of minimal residual disease in acute lymphoblastic leukaemia. J Clin Pathol-Mol Pathol 48:M65, 1995
30. Roberts WM, Estrov Z, Kitchingman GR, Zipf TF: The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification by antigen-receptor gene sequences. Leuk Lymphoma 20:181, 1996
31. Goulden NJ, Knechtli CJC, Garland RJ, Langlands K, Hancock JP, Potter MN, Steward CG, Oakhill A: Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia. Br J Haematol 100:235, 1998
32. Miyamura K, Tanimoto M, Morishima Y, Horibe K, Yamamoto K, Akatsuka M, Kodera Y, Kojima S, Matsuyama K, Hirabayashi N, Yazaki M, Imai K, Onozawa Y, Kanamaru A, Mizutani S, Saito H: Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: Possible eradication of minimal residual disease by marrow transplantation. Blood 79:1366, 1992
33. Mitterbauer G, Fodinger M, Scherrer R, Knobl P, Jager U, Laczika K, Schwarzinger I, Gaiger A, Geissler K, Greinix H, Kalhs P, Linkesch W, Lechner K, Mannhalter C: PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia. Br J Haematol 89:937, 1995
34. Radich J, Ladne P, Gooley T: Polymerase chain reaction-based detection of minimal residual disease in acute lymphoblastic leukemia predicts relapse after allogeneic BMT. Biol Blood Marrow Transplant 1:24, 1995
35. Radich J, Gehly G, Lee A, Avery R, Bryant E, Edmands S, Gooley T, Kessler P, Kirk J, Ladne P, Thomas ED, Appelbaum FR: Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation. Blood 89:2602, 1997
36. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick, HR, Sultan C: Proposals for the classification of the acute leukaemias. French-American-British (FAB) Co-operative Group. Br J Haematol 33:451, 1976
37. Campana D, Coustan-Smith E, Janossy G: Immunophenotyping in haematological diagnosis. Baillieres Clin Haematol 3:889, 1990
38. Chessells JM, Richards SM, Bailey CC, Lilleyman JS, Eden OB: Gender and treatment outcome in childhood lymphoblastic leukaemia: Report from the MRC UKALL trials. Br J Haematol 89:364, 1995
39. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295, 1974
40. Shulman HM, Sullivan KM, Weiden PL, McDonald EB, Striker GE, Sale GE, Hachman R, Tsoi M, Storb R, Thomas ED: Chronic graft versus host syndrome in man: A long-term clinicopathologic study in 20 Seattle patients. Am J Med 69:204, 1980
41. Sambrook J, Fritsch EF, Maniatis T: Commonly used techniques in molecular cloning, in Sambrook J, Fritsch EF, Maniatis T (eds): Molecular Cloning: A Laboratory Manual. New York, NY, Cold Spring Harbor Laboratory, 1989, p E3
42. Steward CG, Goulden NJ, Katz F, Baines D, Martin PG, Langlands K, Potter MN, Chessells JM, Oakhill A: A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood 83:1355, 1994
43. Everitt BS: The analysis of contingency tables. London, UK. Chapman and Hall, 1980
44. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
45. Wingard JR, Piantadosi S, Santos GW, Saral R, Vriesendorp HM, Yeager AM, Burns WH, Ambinder RF, Braine HG, Elfenbein G, Jones RJ, Kaizer H, May WS, Rowley SD, Sensenbrenner LL, Stuart RK, Tutschka PJ, Vogelsang GB, Wagner JE, Beschorner WE, Brookmeyer R, Farmer ER: Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia. J Clin Oncol 8:820, 1990
46. Brochstein JA, Kernan NA, Groshen S, Cirrincione C, Shank B, Emanuel, Laver J, O'Reilly RJ: Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 317:1618, 1987
47. Goulden N, Langlands K, Steward C, Katz F, Potter M, Chessells J, Oakhill A: PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia. Br J Haematol 87:282, 1994
48. O'Reilly J, Meyer B, Baker D, Herrmann R, Cannell P, Davies J: Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia. Leukemia 9:624, 1995
49. Barrett AJ, Horowitz MM, Ash RC, Atkinson K, Gale RP, Goldman JM, Henslee-Downey PJ, Herzig RH, Speck B, Zwaan FE: Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 79:3067, 1992
50. Marks DI, Bird JM, Cornish JM, Goulden NJ, Jones CG, Knechtli CJC, Pamphilon DH, Steward CG, Oakhill A: Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia. J Clin Oncol 16:931, 1998
51. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF: Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 336:317, 1997
52. Hann IM, Morris Jones PH, Evans DIK: Discrepancy of bone- marrow aspirations in acute lymphoblastic leukaemia in relapse. Lancet 1:1215, 1977
53. Martens ACM, Schulz FW, Hagenbeek A: Nonhomogeneous distribution of leukemia cells in the bone marrow during minimal residual disease. Blood 70:1073, 1991
54. van Bekkum DW: Residual reflections on the detection and treatment of leukaemia, in Lowenberg B, Hagenbeek A (eds): Minimal Residual Disease in Acute Leukaemia. Boston, MA, Martinns Nijhoff, 1984, p 385